Trial Profile
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Local Tolerability After Administration of Eye Drop DA-6034 in Healthy Volunteers(Phase I)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2014
Price :
$35
*
At a glance
- Drugs Recoflavone (Primary)
- Indications Dry eyes; Gastritis
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 09 Sep 2014 New trial record